United States · Bill · S
S. 3770 (115th)
Medicaid Drug Decisions Transparency Act
Introduced
18 December 2018
Last action
—
Status
Read twice and referred to the Committee on Finance.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Medicaid Drug Decisions Transparency Act This bill expands Medicaid and Medicare reporting requirements related to the transparency of physician ownership or investment interests to include pharmacists and individuals with authority over Medicaid formularies, and also increases civil penalties for violations.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 18 December 2018
Introduced in Senate (PDF)
Introduced in Senate · EN · 18 December 2018
Introduced in Senate
summary · EN · 18 December 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/3770
- Open data entity: https://api.congress.gov/v3/bill/115/s/3770